Dentists not heeding ADA’s call to seal noncavitated lesions
By Rob Goszkowski, Assistant Editor Dr. Bicuspid September 1, 2011 — As it rolls out clinical recommendations, the ADA is on a mission to guide general … more
By Rob Goszkowski, Assistant Editor Dr. Bicuspid September 1, 2011 — As it rolls out clinical recommendations, the ADA is on a mission to guide general … more
Florida-based biopharmaceutical company Oragenics, Inc. (OTCBB: ORNI) announced its intention to commence a second phase 1 clinical trial of SMaRT Replacement Therapy. The Company has … more